Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years

NCT06891417 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

1560

Enrollment

INDUSTRY

Sponsor class

Conditions

Chlamydia Trachomatis Immunization

Interventions

BIOLOGICAL: Chlamydia mRNA Vaccine
OTHER: Placebo

Sponsor

Sanofi